← Back to Search

Genetic Testing

Genetic Testing for Cancer Risk

N/A
Recruiting
Led By Niloy J Samadder
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients at least 18 years of age
Be older than 18 years old
Must not have
Patients who have had prior germline genetic testing involving a 40+ gene panel within the last 24 months at Mayo Clinic and available for review by the research coordinator at time of consent
Past or current history of hematological cancer (including leukemias, multiple myeloma)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study completion (2 years)
Awards & highlights

Summary

This trial looks at how well cancer genetic testing works in different ethnic groups. It could help find cancer genes and other people at risk. The info could also help with cancer risk stratification ( figuring out who is most likely to get cancer) and individualized screening ( tests specifically for the person being tested).

Who is the study for?
This trial is for adults from diverse ethnic backgrounds, including Hispanic/Latino, Native American/Alaskan, African American, Asian and European descent who have solid tumor cancers. They must be able to provide a blood sample and agree to genetic testing at Mayo Clinic in Arizona or Florida.
What is being tested?
The study focuses on collecting biospecimens and conducting genetic tests among various ethnic groups. It aims to identify cancer genes for better risk assessment and personalized screening strategies.
What are the potential side effects?
There are generally no direct side effects from participating in this trial as it involves non-invasive procedures like blood collection and genetic testing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I had a genetic test with 40+ genes at Mayo Clinic in the last 2 years, and the results can be reviewed.
Select...
I have or had blood cancer, like leukemia or multiple myeloma.
Select...
I have had a bone marrow transplant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study completion (2 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and study completion (2 years) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Impact of germline genetic testing on both therapeutic management and targeted cancer prevention
Prevalence of pathogenic germline mutations in enrolled patients within each cancer site
Prevalence of positive pathogenic germline mutations
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Screening (biospecimen collection)Experimental Treatment2 Interventions
Patients undergo collection of blood or saliva sample for genetic testing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 3
~2020

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,001,200 Total Patients Enrolled
Mayo ClinicLead Sponsor
3,298 Previous Clinical Trials
3,956,645 Total Patients Enrolled
Niloy J SamadderPrincipal InvestigatorMayo Clinic
6 Previous Clinical Trials
1,303 Total Patients Enrolled

Media Library

Cancer Genetic Testing (Genetic Testing) Clinical Trial Eligibility Overview. Trial Name: NCT04475640 — N/A
Head and Neck Cancers Research Study Groups: Screening (biospecimen collection)
Head and Neck Cancers Clinical Trial 2023: Cancer Genetic Testing Highlights & Side Effects. Trial Name: NCT04475640 — N/A
Cancer Genetic Testing (Genetic Testing) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04475640 — N/A
~0 spots leftby Oct 2024